newsfilter
← Latest News
GlobeNewswire·

Apexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ Platform

SAN CARLOS, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. ("Apexigen"), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that it